Omega Therapeutics, Inc.
OMGAQ
$0.055
$0.0122.22%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.85% | 19.00% | 0.42% | 9.14% | 25.06% |
| Total Depreciation and Amortization | 405.55% | -66.24% | 1.97% | -4.45% | 2.47% |
| Total Amortization of Deferred Charges | -8.33% | 0.00% | -40.00% | 53.85% | 18.18% |
| Total Other Non-Cash Items | 42.21% | -64.65% | 61.16% | -6.91% | 32.81% |
| Change in Net Operating Assets | -234.04% | -41.44% | 480.27% | 83.73% | -273.00% |
| Cash from Operations | -10.60% | -7.34% | 30.92% | 25.81% | 1.01% |
| Capital Expenditure | 95.96% | 25.98% | 51.85% | -53.45% | 29.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 92.23% | -- | -100.00% |
| Cash from Investing | 95.96% | -108.87% | 108.64% | 395.58% | -103.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29.92% | -1.92% | -9.20% | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 1,000.00% | -71.43% | -98.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 90.13% |
| Cash from Financing | -29.74% | -4.02% | -165.85% | 20,412.50% | -103.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.12% | -68.62% | 36.89% | 43.94% | -2,486.45% |